CPHI Frankfurt is right around the corner! Are you planning to attend? Are you in need of pharma innovation, formulation development, bioanalysis, clinical trials, quality control or GMP manufacturing? Then come meet us at CPHI in Frankfurt, Germany, from the 1st to the 3rd of November. You will find us at stand #41M21 in Hall 4.1. Otherwise you may contact us at sales@quinta.cz to arrange a visit. Our entire QUINTA-ANALYTICA commercial team will be attending in addition to senior management and most importantly our colleagues from the Conscio Group, Conscio Pharmaceuticals, Gen-Plus GmbH & Co. KG, DiHeSys GmbH and BBA Capitalpartners GmbH. We look forward to seeing you in Frankfurt. #cphifrankfurt #cphi2022

Additional News

  • 16 April 2026

    Expanding Beyond FDA & EMA: Strengthening Our Global Regulatory Footprint with GCC

    Quinta-Analytica has successfully completed a full on-site GCP inspection within the GCC framework, further strengthening its international regulatory footprint and clinical research credibility.

  • 25 March 2026

    ADC Webinar: DAR, Bioanalysis and Intact MS in Next-Generation ADC Development

    On behalf of Conscio Group, registration is now open for our free expert-led webinar on DAR characterization, bioanalytical strategy and mass spectrometry insight in ADC development.

  • 17 December 2025

    PF 2026: Thank You from Quinta-Analytica

    In 2025, Quinta-Analytica continued to turn complex development challenges into tangible progress. Our PF 2026 message looks back at key milestones and thanks the partners, clients, and teams who made them possible.

ALL POSTS